Kistler-Tiffany Companies’s GSK GSK Stock Holding History

Kistler-Tiffany Companies’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$501K	Buy	14,064 +199	+1%	+$7.14K	0.08%	197
2023 Q1	$493K	Buy	13,865 +4,562	+49%	+$160K	0.09%	162
2022 Q4	$327K	Sell	9,303 -1,030	-10%	-$34.3K	0.07%	186
2022 Q3	$304K	Buy	10,333 +786	+8%	+$29.8K	0.07%	163
2022 Q2	$519K	Sell	9,547 -12,130	-56%	-$670K	0.11%	121
2022 Q1	$1.18M	Buy	21,677 +18,720	+633%	+$1.02M	0.22%	75
2021 Q4	$163K	Sell	2,957 -529	-15%	-$27.5K	0.03%	219
2021 Q3	$166K	Sell	3,486 -358	-9%	-$18K	0.04%	207
2021 Q2	$191K	Buy	3,844 +553	+17%	+$26.6K	0.04%	192
2021 Q1	$147K	Buy	3,291 +264	+9%	+$12K	0.04%	199
2020 Q4	$139K	Sell	3,027 -960	-24%	-$44.1K	0.04%	187
2020 Q3	$188K	Buy	3,987 +2,022	+103%	+$101K	0.06%	150
2020 Q2	$100K	Hold	1,965	–	–	0.04%	198
2020 Q1	$115K	Hold	1,965	–	–	0.04%	184
2019 Q4	$115K	Sell	1,965 -84	-4%	-$4.67K	0.04%	189
2019 Q3	$109K	Hold	2,049	–	–	0.04%	191
2019 Q2	$102K	Hold	2,049	–	–	0.04%	190
2019 Q1	$107K	Hold	2,049	–	–	0.04%	186
2018 Q4	$98K	Hold	2,049	–	–	0.05%	177
2018 Q3	$103K	Buy	2,049 +84	+4%	+$4.27K	0.04%	183
2018 Q2	$99K	Sell	1,965 -51	-3%	-$2.57K	0.04%	189
2018 Q1	$98K	Sell	2,016 -560	-22%	-$26.1K	0.04%	198
2017 Q4	$114K	Hold	2,576	–	–	0.05%	198
2017 Q3	$131K	Buy	2,576 +81	+3%	+$4.11K	0.05%	178
2017 Q2	$134K	Hold	2,495	–	–	0.06%	164
2017 Q1	$131K	Hold	2,495	–	–	0.06%	163
2016 Q4	$120K	Hold	2,495	–	–	0.06%	165
2016 Q3	$135K	Sell	2,495 -11	-0.4%	-$603	0.07%	158
2016 Q2	$136K	Sell	2,506 -469	-16%	-$24.7K	0.07%	157
2016 Q1	$151K	Sell	2,975 -87	-3%	-$4.33K	0.08%	140
2015 Q4	$154K	Buy	3,062 +567	+23%	+$28.9K	0.08%	143
2015 Q3	$120K	Sell	2,495 -932	-27%	-$48.5K	0.07%	167
2015 Q2	$178K	Buy	3,427 +983	+40%	+$55.3K	0.11%	136
2015 Q1	$141K	Hold	2,444	–	–	0.09%	136
2014 Q4	$131K	Sell	2,444 -220	-8%	-$12.3K	0.09%	144
2014 Q3	$153K	Buy	2,664 +220	+9%	+$13.5K	0.1%	129
2014 Q2	$163K	Hold	2,444	–	–	0.12%	116
2014 Q1	$163K	Hold	2,444	–	–	0.12%	108
2013 Q4	$163K	Hold	2,444	–	–	0.12%	109
2013 Q3	$153K	Sell	2,444 -78	-3%	-$5.02K	0.12%	110
2013 Q2	$158K	Buy	+2,522	New	+$160K	0.14%	107

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kistler-Tiffany Companies's GSK Position: Q2 2023 in Review

Kistler-Tiffany Companies increased its GSK (GSK) stake by 1.4% in Q2 2023, buying an estimated $7.14K and bringing the position to 14,064 shares worth $501K. The position accounts for 0.08% of the portfolio, ranked #197.

Kistler-Tiffany Companies first reported a position in GSK in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.18M in Q1 2022. 827 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

Kistler-Tiffany Companies held 14,064 shares of GSK worth $501K as of Q2 2023.
Kistler-Tiffany Companies bought 199 GSK shares in Q2 2023, an estimated $7.14K.
GSK made up 0.08% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #197 holding.
Kistler-Tiffany Companies first reported a position in GSK in Q2 2013 and has held it in 41 quarters since.
Kistler-Tiffany Companies's GSK position peaked at $1.18M in Q1 2022.
827 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.